First City Capital Management, Inc. Amgen Inc Transaction History

First City Capital Management, Inc.

$164 Million
Q1 2025

A detailed history of First City Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, First City Capital Management, Inc. holds 3,401 shares of AMGN stock, worth $943,063. This represents 0.65% of its overall portfolio holdings.

Number of Shares

3,401

Previous 3,755 9.43%

Holding current value

$943,063

Previous $978,000 8.28%

% of portfolio

0.65%

Previous 0.53%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	SELL	$258.59 - $327.36 $91,540 - $115,885	-354 Reduced 9.43%	3,401 $1.06 Million
Q4 2024 Jan 03, 2025	SELL	$258.78 - $328.31 $258 - $328	-1 Reduced 0.03%	3,755 $978,000
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $9,281 - $10,121	-30 Reduced 0.79%	3,756 $1.21 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $6,568 - $7,982	-25 Reduced 0.66%	3,786 $1.18 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $3,835 - $4,326	-15 Reduced 0.39%	3,811 $1.1 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $2,623 - $3,257	12 Added 0.31%	3,826 $1.03 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $18,212 - $21,536	85 Added 2.28%	3,814 $846,000
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $65,027 - $79,257	-288 Reduced 7.17%	3,729 $901,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $48,783 - $61,985	213 Added 5.6%	4,017 $1.06 Million
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $85,294 - $96,197	380 Added 11.1%	3,804 $857,000
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $5,767 - $6,418	-25 Reduced 0.72%	3,424 $833,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $14,471 - $16,009	66 Added 1.95%	3,449 $834,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $32,815 - $37,554	165 Added 5.13%	3,383 $751,000
Q3 2021 Oct 28, 2021	BUY	$212.27 - $248.7 $25,472 - $29,844	120 Added 3.87%	3,218 $684,000
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $467 - $518	-2 Reduced 0.06%	3,098 $707,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $443 - $517	2 Added 0.06%	3,100 $778,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $554,581 - $660,408	-2,563 Reduced 45.27%	3,098 $728,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $543,214 - $604,099	2,315 Added 69.19%	5,661 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $21,956 - $26,944	111 Added 3.43%	3,346 $789,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $20,046 - $26,587	110 Added 3.52%	3,235 $656,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1,513 - $1,945	-8 Reduced 0.26%	3,125 $753,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $124,257 - $140,065	-687 Reduced 17.98%	3,133 $595,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 1.29%	3,820 $792,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $4,151 - $4,662	-25 Reduced 0.64%	3,870 $714,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $21,098 - $23,573	-125 Reduced 3.11%	3,895 $677,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,020	4,020 $692,000

Others Institutions Holding AMGN

# of Institutions

3,214

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Amgen Inc Transaction History